Greenville, MS8 Active Studies

Pulmonary Embolism Clinical Trials in Greenville, MS

Find 8 actively recruiting pulmonary embolism clinical trials in Greenville, MS. Connect with local research sites and explore new treatment options.

8
Active Trials
8
Sponsors
1,399
Enrolling

Recruiting Pulmonary Embolism Studies in Greenville

About Pulmonary Embolism Clinical Trials in Greenville

Pulmonary embolism (PE) is a blockage of an artery in the lungs, usually caused by blood clots that travel from the deep veins of the legs. It can be life-threatening and requires immediate medical attention. Treatment includes anticoagulants and in severe cases, thrombolytic therapy.

There are currently 8 pulmonary embolism clinical trials recruiting participants in Greenville, MS. These studies are seeking a combined 1,399 participants. Research is being sponsored by University of Alabama at Birmingham, Angiodynamics, Inc., AstraZeneca and 5 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Pulmonary Embolism Clinical Trials in Greenville — FAQ

Are there pulmonary embolism clinical trials in Greenville?

Yes, there are 8 pulmonary embolism clinical trials currently recruiting in Greenville, MS. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Greenville?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Greenville research site will contact you about next steps.

Are clinical trials in Greenville free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Greenville studies also compensate for your time and travel.

What pulmonary embolism treatments are being tested?

The 8 active trials in Greenville are testing new therapies including novel drugs, biologics, and treatment approaches for pulmonary embolism.

Data updated July 13, 2026 from ClinicalTrials.gov